JPRN-UMIN000002619已完成未知
Phase II study of amrubicin combined with carboplatin for unresectable invasive thymoma or thymic carcinoma - Amrubicin and carboplatin for invasive thymoma/thymic carcinoma
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Severe co-morbidities 2. Symptomatic brain metastasis 3. Massive effusion that require drainage 4. Pregnant woman
研究者
相似试验
已完成
不适用
Phase II study of amrubicin combined with carboplatin for refractory relapsed small-cell lung cancerJPRN-UMIN000002618Tohoku University Hospital30
已完成
2 期
A phase II study of carboplatin and amurubicin with a biweekly schedule in patients with advanced squamous cell lung canceron-Small Cell Lung Cancer,Squamous cell lung cancerJPRN-UMIN000007102ational Hospital Organization Kyushu Medical Center Department of Respiratory Medicine25
已完成
2 期
A phase II study of amrubicin for previously treated small cell lung cancerFor patients with recurrent small cell lung cancerJPRN-UMIN000001752Gunma University Hospital35
已完成
1 期
Phase 1-2 Study of Amrubicin plus Nedaplatin for Advanced Non-Small-Cell Lung Canceron-Small-Cell Lung CancerJPRN-UMIN000003282agasaki University Hospital35
已完成
2 期
Phase II study of amrubicin for previously treated advanced non-small cell lung cancerRecurrent non-small cell lung cancerJPRN-UMIN000001751Gunma University Hospital35